11.10.26 -- Why Early Evaluation Of Process Parameters Matters In OSD Scale-Up

Discover how ultra-sensitive spectroscopy transforms decontamination validation, revealing hidden efficiencies that safely cut facility downtime while ensuring absolute safety.

Modern single-use virus filtration automates critical processing steps, slashes turnaround times, and optimizes scalability across bioprocessing workflows.

Learn how embedding a contamination control strategy into early facility design mitigates risk, protects product quality, and ensures regulatory compliance.

Agentic AI is redefining manufacturing by accelerating batch release and sharpening real‑time insights. With the right data and governance, teams can gain faster analytics and improved efficiency.

If you’re launching an international clinical trial, consider the noteworthy benefits of partnering with an in-country depot, including increased efficiency, reduced costs, and reliable access to raw materials.

Gain insight into how a global operations team accelerated digital adoption through scalable governance, as well as their roadmap for deeper system integration and AI‑enabled workflows.

Classifying eye drops as combination products complicates approval. Read about how identifying the primary mode of action early and aligning dual quality frameworks prevents costly launch delays.

Nanoparticle engineering enabled a 440 mg/mL trastuzumab suspension that clears viscosity and stability barriers limiting conventional high-dose subcutaneous biologics formulations.

Explore how our on-body delivery system supports high-volume biologic delivery by balancing usability, patient needs, and sustainability through research-driven design.

High-throughput water endotoxin testing doesn’t have to sacrifice consistency. Take a look into how an automated workflow delivers reliable results, low variability, and strong control recovery.

Ensuring adequate solubility is crucial for small molecule drugs' effectiveness. Find out how poor solubility remains a significant challenge, potentially hindering medications from reaching the market.

With only 105 FDA-approved excipients for nasal and inhalation routes, formulating biologics for respiratory delivery demands precise excipient selection across both liquid and solid dosage forms.

Recent liver safety concerns highlight the limits of conventional preclinical testing. Human-relevant models could help researchers detect drug-induced liver injury earlier and reduce costly setbacks.

In our series on pre-filled syringes, we explore five key ways this delivery format is enhancing patient outcomes, not just through the medicine it contains, but through the device design itself.

Complex formulations, HPAPIs, and modified-release products demand early planning. Formulation strategy, tech transfer, infrastructure, and partner selection largely determine scale-up success.

Successful drug development and manufacturing rely on strong communication. Early collaboration and active listening help teams reduce risk, align expectations, and solve challenges.

Examine how effective technology transfer strategies can streamline scale-up, maintain product quality, and enable successful clinical and commercial manufacturing.

Late-phase OSD scale-up demands more than technical know-how. Uncover the frameworks, tools, and partnership models that determine whether promising molecules reach commercial production reliably.

Pharmaceutical companies must prioritize patient-centric dosage forms to address challenges like dysphagia, enhance medication compliance, and improve therapeutic outcomes.

Drug developers must successfully navigate the path to market, under the growing pressure of regulation and competition, and while carefully managing technical and financial risk.

Self-driving labs bring automation and AI together to transform research. Understand how continuous experimentation and real-time learning unlock faster insights and more efficient paths to innovation.